Key points are not available for this paper at this time.
Abstract Background Labelled with lutetium-177, the urea-based small molecules PSMA I P = 0.89). Conclusion In this matched-pair analysis of patients receiving one of the two agents most frequently applied for PSMA RLT, the rate of clinically relevant toxicities was low for both compounds. In addition, no relevant differences for OS were observed.
Hartrampf et al. (Fri,) studied this question.